Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis | Synapse
May 6, 2024
Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)